These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Omeprazole in the therapy of acid-induced diseases]. Simon B, Dammann HG, Müller P. Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299 [Abstract] [Full Text] [Related]
24. [The present state of knowledge on the treatment of peptic diseases with cimetidine]. Romankiewicz JA, Reidenberg MM. Internist (Berl); 1981 Dec; 22(12):762-6. PubMed ID: 6797984 [No Abstract] [Full Text] [Related]
32. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. Bown RL. Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700 [Abstract] [Full Text] [Related]
33. [Experience in the use of losek (omeprazole) in gastroenterology]. Maev IV, V'iuchnova ES, Lebedev EG, Dicheva DT, Ovsiannikova EV, Antonenko OM, Shchekina MI. Ter Arkh; 2001 Mar; 73(7):79-82. PubMed ID: 11523419 [No Abstract] [Full Text] [Related]
34. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg]. Arnold R. Fortschr Med; 1994 Jan 20; 112(1-2):44-5. PubMed ID: 8144120 [No Abstract] [Full Text] [Related]
40. [Omeprazole and maintenance treatment: new concepts for traditional therapies?]. Díaz de Rojas F, Ponce García J. An Med Interna; 1992 Sep 20; 9(9):450-4. PubMed ID: 1391583 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]